nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—PGR—polycystic ovary syndrome	0.22	0.291	CbGaD
Danazol—SHBG—polycystic ovary syndrome	0.206	0.272	CbGaD
Danazol—AR—polycystic ovary syndrome	0.18	0.238	CbGaD
Danazol—CYP19A1—polycystic ovary syndrome	0.151	0.199	CbGaD
Danazol—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0154	0.139	CbGeAlD
Danazol—CCL2—tunica intima—polycystic ovary syndrome	0.0125	0.113	CbGeAlD
Danazol—PGR—corpus luteum—polycystic ovary syndrome	0.00988	0.0891	CbGeAlD
Danazol—CYP19A1—corpus luteum—polycystic ovary syndrome	0.00889	0.0802	CbGeAlD
Danazol—PGR—ovarian follicle—polycystic ovary syndrome	0.00773	0.0697	CbGeAlD
Danazol—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.00696	0.0627	CbGeAlD
Danazol—ESR1—ovarian follicle—polycystic ovary syndrome	0.00605	0.0545	CbGeAlD
Danazol—CCL2—embryo—polycystic ovary syndrome	0.00199	0.0179	CbGeAlD
Danazol—GNRHR—pituitary gland—polycystic ovary syndrome	0.00169	0.0152	CbGeAlD
Danazol—CCL2—adrenal cortex—polycystic ovary syndrome	0.00163	0.0147	CbGeAlD
Danazol—CCL2—endometrium—polycystic ovary syndrome	0.00146	0.0131	CbGeAlD
Danazol—CYP3A4—urine—polycystic ovary syndrome	0.00141	0.0127	CbGeAlD
Danazol—GNRHR—female gonad—polycystic ovary syndrome	0.00141	0.0127	CbGeAlD
Danazol—Trilostane—HSD3B1—polycystic ovary syndrome	0.00135	0.173	CrCbGaD
Danazol—CCL2—uterus—polycystic ovary syndrome	0.00134	0.0121	CbGeAlD
Danazol—CCL2—pituitary gland—polycystic ovary syndrome	0.00132	0.0119	CbGeAlD
Danazol—CCL2—adipose tissue—polycystic ovary syndrome	0.00131	0.0118	CbGeAlD
Danazol—GNRHR—endocrine gland—polycystic ovary syndrome	0.00131	0.0118	CbGeAlD
Danazol—CCL2—adrenal gland—polycystic ovary syndrome	0.00118	0.0106	CbGeAlD
Danazol—CCL2—female gonad—polycystic ovary syndrome	0.0011	0.00989	CbGeAlD
Danazol—CCL2—vagina—polycystic ovary syndrome	0.00109	0.00983	CbGeAlD
Danazol—CCL2—endocrine gland—polycystic ovary syndrome	0.00102	0.0092	CbGeAlD
Danazol—Trilostane—HSD3B2—polycystic ovary syndrome	0.000909	0.117	CrCbGaD
Danazol—SHBG—endometrium—polycystic ovary syndrome	0.000849	0.00765	CbGeAlD
Danazol—ESR1—embryo—polycystic ovary syndrome	0.000817	0.00737	CbGeAlD
Danazol—SHBG—uterus—polycystic ovary syndrome	0.000782	0.00705	CbGeAlD
Danazol—SHBG—pituitary gland—polycystic ovary syndrome	0.000768	0.00693	CbGeAlD
Danazol—SHBG—adipose tissue—polycystic ovary syndrome	0.000765	0.0069	CbGeAlD
Danazol—PGR—endometrium—polycystic ovary syndrome	0.000765	0.00689	CbGeAlD
Danazol—PGR—uterus—polycystic ovary syndrome	0.000705	0.00635	CbGeAlD
Danazol—PGR—pituitary gland—polycystic ovary syndrome	0.000692	0.00624	CbGeAlD
Danazol—PGR—adipose tissue—polycystic ovary syndrome	0.000689	0.00621	CbGeAlD
Danazol—CYP19A1—endometrium—polycystic ovary syndrome	0.000688	0.0062	CbGeAlD
Danazol—SHBG—adrenal gland—polycystic ovary syndrome	0.000686	0.00619	CbGeAlD
Danazol—AR—adrenal cortex—polycystic ovary syndrome	0.000682	0.00615	CbGeAlD
Danazol—SHBG—female gonad—polycystic ovary syndrome	0.00064	0.00577	CbGeAlD
Danazol—SHBG—vagina—polycystic ovary syndrome	0.000636	0.00573	CbGeAlD
Danazol—CYP19A1—uterus—polycystic ovary syndrome	0.000634	0.00572	CbGeAlD
Danazol—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00062	0.00559	CbGeAlD
Danazol—PGR—adrenal gland—polycystic ovary syndrome	0.000618	0.00557	CbGeAlD
Danazol—AR—endometrium—polycystic ovary syndrome	0.000609	0.00549	CbGeAlD
Danazol—ESR1—endometrium—polycystic ovary syndrome	0.000598	0.00539	CbGeAlD
Danazol—SHBG—endocrine gland—polycystic ovary syndrome	0.000595	0.00537	CbGeAlD
Danazol—PGR—female gonad—polycystic ovary syndrome	0.000576	0.0052	CbGeAlD
Danazol—PGR—vagina—polycystic ovary syndrome	0.000573	0.00517	CbGeAlD
Danazol—AR—uterus—polycystic ovary syndrome	0.000561	0.00506	CbGeAlD
Danazol—CYP19A1—adrenal gland—polycystic ovary syndrome	0.000556	0.00502	CbGeAlD
Danazol—AR—pituitary gland—polycystic ovary syndrome	0.000551	0.00497	CbGeAlD
Danazol—ESR1—uterus—polycystic ovary syndrome	0.000551	0.00497	CbGeAlD
Danazol—AR—adipose tissue—polycystic ovary syndrome	0.000549	0.00495	CbGeAlD
Danazol—ESR1—pituitary gland—polycystic ovary syndrome	0.000541	0.00488	CbGeAlD
Danazol—ESR1—adipose tissue—polycystic ovary syndrome	0.000539	0.00486	CbGeAlD
Danazol—PGR—endocrine gland—polycystic ovary syndrome	0.000536	0.00483	CbGeAlD
Danazol—CYP19A1—female gonad—polycystic ovary syndrome	0.000519	0.00468	CbGeAlD
Danazol—AR—adrenal gland—polycystic ovary syndrome	0.000493	0.00444	CbGeAlD
Danazol—ESR1—adrenal gland—polycystic ovary syndrome	0.000484	0.00436	CbGeAlD
Danazol—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000482	0.00435	CbGeAlD
Danazol—AR—female gonad—polycystic ovary syndrome	0.000459	0.00414	CbGeAlD
Danazol—AR—vagina—polycystic ovary syndrome	0.000456	0.00412	CbGeAlD
Danazol—ESR1—female gonad—polycystic ovary syndrome	0.000451	0.00406	CbGeAlD
Danazol—ESR1—vagina—polycystic ovary syndrome	0.000448	0.00404	CbGeAlD
Danazol—Levonorgestrel—SRD5A1—polycystic ovary syndrome	0.000437	0.0561	CrCbGaD
Danazol—AR—endocrine gland—polycystic ovary syndrome	0.000427	0.00385	CbGeAlD
Danazol—ESR1—endocrine gland—polycystic ovary syndrome	0.000419	0.00378	CbGeAlD
Danazol—Stanozolol—AR—polycystic ovary syndrome	0.000365	0.0469	CrCbGaD
Danazol—Oxandrolone—AR—polycystic ovary syndrome	0.000329	0.0422	CrCbGaD
Danazol—Norelgestromin—PGR—polycystic ovary syndrome	0.000287	0.0369	CrCbGaD
Danazol—Desogestrel—PGR—polycystic ovary syndrome	0.000277	0.0355	CrCbGaD
Danazol—Desogestrel—SHBG—polycystic ovary syndrome	0.000258	0.0332	CrCbGaD
Danazol—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000234	0.00211	CbGeAlD
Danazol—Etonogestrel—PGR—polycystic ovary syndrome	0.000224	0.0287	CrCbGaD
Danazol—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.00022	0.0282	CrCbGaD
Danazol—Etonogestrel—SHBG—polycystic ovary syndrome	0.000209	0.0269	CrCbGaD
Danazol—Testolactone—CYP19A1—polycystic ovary syndrome	0.000206	0.0264	CrCbGaD
Danazol—Levonorgestrel—PGR—polycystic ovary syndrome	0.000158	0.0203	CrCbGaD
Danazol—Levonorgestrel—SHBG—polycystic ovary syndrome	0.000148	0.019	CrCbGaD
Danazol—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.000141	0.0181	CrCbGaD
Danazol—Testosterone Propionate—AR—polycystic ovary syndrome	0.000133	0.0171	CrCbGaD
Danazol—Levonorgestrel—AR—polycystic ovary syndrome	0.00013	0.0167	CrCbGaD
Danazol—Norethindrone—PGR—polycystic ovary syndrome	0.000128	0.0165	CrCbGaD
Danazol—Cortisone acetate—NR3C1—polycystic ovary syndrome	0.000128	0.0164	CrCbGaD
Danazol—Ethinyl Estradiol—SHBG—polycystic ovary syndrome	0.000125	0.016	CrCbGaD
Danazol—Fluoxymesterone—AR—polycystic ovary syndrome	0.000124	0.0159	CrCbGaD
Danazol—Norethindrone—SHBG—polycystic ovary syndrome	0.00012	0.0154	CrCbGaD
Danazol—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000114	0.0146	CrCbGaD
Danazol—Levonorgestrel—CYP19A1—polycystic ovary syndrome	0.000109	0.0139	CrCbGaD
Danazol—Progesterone—CYP17A1—polycystic ovary syndrome	0.000101	0.0129	CrCbGaD
Danazol—Methyltestosterone—AR—polycystic ovary syndrome	9.99e-05	0.0128	CrCbGaD
Danazol—Testosterone—CYP11A1—polycystic ovary syndrome	9.38e-05	0.012	CrCbGaD
Danazol—Hydrocortisone—SHBG—polycystic ovary syndrome	8.58e-05	0.011	CrCbGaD
Danazol—Fluoxymesterone—NR3C1—polycystic ovary syndrome	8.39e-05	0.0108	CrCbGaD
Danazol—Methyltestosterone—CYP19A1—polycystic ovary syndrome	8.36e-05	0.0107	CrCbGaD
Danazol—Progesterone—PGR—polycystic ovary syndrome	7.48e-05	0.0096	CrCbGaD
Danazol—Prednisone—NR3C1—polycystic ovary syndrome	7.24e-05	0.00929	CrCbGaD
Danazol—Progesterone—SHBG—polycystic ovary syndrome	6.99e-05	0.00897	CrCbGaD
Danazol—Testosterone—SHBG—polycystic ovary syndrome	6.61e-05	0.00848	CrCbGaD
Danazol—Progesterone—AR—polycystic ovary syndrome	6.13e-05	0.00787	CrCbGaD
Danazol—Testosterone—AR—polycystic ovary syndrome	5.79e-05	0.00744	CrCbGaD
Danazol—Hydrocortisone—NR3C1—polycystic ovary syndrome	5.1e-05	0.00655	CrCbGaD
Danazol—Testosterone—CYP19A1—polycystic ovary syndrome	4.85e-05	0.00622	CrCbGaD
Danazol—Progesterone—NR3C1—polycystic ovary syndrome	4.16e-05	0.00533	CrCbGaD
Danazol—Progesterone—CYP1A1—polycystic ovary syndrome	3.77e-05	0.00484	CrCbGaD
Danazol—Testosterone—CYP1A1—polycystic ovary syndrome	3.57e-05	0.00458	CrCbGaD
Danazol—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	3.27e-05	0.000262	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	3.24e-05	0.00026	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.21e-05	0.000257	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	3.2e-05	0.000257	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	3.2e-05	0.000256	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	3.2e-05	0.000256	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.18e-05	0.000255	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.18e-05	0.000255	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	3.18e-05	0.000255	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.16e-05	0.000253	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PGR—polycystic ovary syndrome	3.13e-05	0.000251	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	3.11e-05	0.000249	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.07e-05	0.000246	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	3.07e-05	0.000246	CbGpPWpGaD
Danazol—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	3.07e-05	0.000246	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	3.04e-05	0.000244	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.04e-05	0.000243	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	3.03e-05	0.000243	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	3.02e-05	0.000242	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.01e-05	0.000241	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.01e-05	0.000241	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.96e-05	0.000237	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	2.95e-05	0.000236	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	2.95e-05	0.000236	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.92e-05	0.000234	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.92e-05	0.000234	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GHRL—polycystic ovary syndrome	2.91e-05	0.000233	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PLAT—polycystic ovary syndrome	2.91e-05	0.000233	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	2.88e-05	0.000231	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	2.87e-05	0.00023	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FST—polycystic ovary syndrome	2.85e-05	0.000228	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	2.83e-05	0.000227	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.81e-05	0.000225	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	2.81e-05	0.000225	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.8e-05	0.000225	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.8e-05	0.000225	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.78e-05	0.000223	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	2.78e-05	0.000223	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PRL—polycystic ovary syndrome	2.78e-05	0.000223	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	2.78e-05	0.000223	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ATF1—polycystic ovary syndrome	2.78e-05	0.000223	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.77e-05	0.000222	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.72e-05	0.000218	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	2.72e-05	0.000218	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.71e-05	0.000217	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.7e-05	0.000216	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.68e-05	0.000214	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	2.67e-05	0.000214	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.67e-05	0.000214	CbGpPWpGaD
Danazol—AR—Gene Expression—YAP1—polycystic ovary syndrome	2.65e-05	0.000212	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.63e-05	0.000211	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.63e-05	0.000211	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.63e-05	0.000211	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	2.61e-05	0.000209	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	2.56e-05	0.000205	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	2.56e-05	0.000205	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NGFR—polycystic ovary syndrome	2.56e-05	0.000205	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—POMC—polycystic ovary syndrome	2.55e-05	0.000204	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PRL—polycystic ovary syndrome	2.54e-05	0.000204	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	2.52e-05	0.000202	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	2.51e-05	0.000201	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.49e-05	0.000199	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.45e-05	0.000196	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.44e-05	0.000196	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	2.44e-05	0.000196	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	2.42e-05	0.000194	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.41e-05	0.000193	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.4e-05	0.000192	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	2.39e-05	0.000192	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.39e-05	0.000191	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.37e-05	0.00019	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.36e-05	0.000189	CbGpPWpGaD
Danazol—PGR—Gene Expression—AR—polycystic ovary syndrome	2.36e-05	0.000189	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.34e-05	0.000188	CbGpPWpGaD
Danazol—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	2.34e-05	0.000187	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	2.33e-05	0.000187	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.33e-05	0.000186	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.33e-05	0.000186	CbGpPWpGaD
Danazol—AR—Gene Expression—PGR—polycystic ovary syndrome	2.31e-05	0.000185	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.28e-05	0.000183	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.26e-05	0.000181	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	2.26e-05	0.000181	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.25e-05	0.00018	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.24e-05	0.000179	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GNAS—polycystic ovary syndrome	2.23e-05	0.000179	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	2.23e-05	0.000179	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	2.21e-05	0.000177	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	2.18e-05	0.000175	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	2.13e-05	0.000171	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.13e-05	0.000171	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.13e-05	0.000171	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.11e-05	0.000169	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.11e-05	0.000169	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NRG1—polycystic ovary syndrome	2.09e-05	0.000167	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.08e-05	0.000167	CbGpPWpGaD
Danazol—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	2.06e-05	0.000165	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.06e-05	0.000165	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.06e-05	0.000165	CbGpPWpGaD
Danazol—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	2.04e-05	0.000164	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.03e-05	0.000162	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.99e-05	0.00016	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.96e-05	0.000157	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—LEP—polycystic ovary syndrome	1.91e-05	0.000153	CbGpPWpGaD
Danazol—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	1.91e-05	0.000153	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.9e-05	0.000152	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	1.88e-05	0.00015	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	1.87e-05	0.00015	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	1.84e-05	0.000147	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	1.84e-05	0.000147	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	1.84e-05	0.000147	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	1.8e-05	0.000145	CbGpPWpGaD
Danazol—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	1.8e-05	0.000144	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IRS2—polycystic ovary syndrome	1.79e-05	0.000143	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PGR—polycystic ovary syndrome	1.78e-05	0.000143	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	1.77e-05	0.000142	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.76e-05	0.000141	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—LEP—polycystic ovary syndrome	1.75e-05	0.00014	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	1.75e-05	0.00014	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	1.72e-05	0.000137	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.71e-05	0.000137	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.71e-05	0.000137	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	1.7e-05	0.000136	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.7e-05	0.000136	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.69e-05	0.000136	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.68e-05	0.000135	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.68e-05	0.000135	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	1.67e-05	0.000134	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.67e-05	0.000134	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.65e-05	0.000132	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—POMC—polycystic ovary syndrome	1.64e-05	0.000132	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—INS—polycystic ovary syndrome	1.64e-05	0.000131	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	1.63e-05	0.000131	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	1.62e-05	0.00013	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	1.62e-05	0.00013	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	1.6e-05	0.000128	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.6e-05	0.000128	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.59e-05	0.000127	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.58e-05	0.000127	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.58e-05	0.000127	CbGpPWpGaD
Danazol—AR—Gene Expression—NCOR1—polycystic ovary syndrome	1.57e-05	0.000126	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.56e-05	0.000125	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.56e-05	0.000125	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.54e-05	0.000124	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	1.53e-05	0.000123	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.52e-05	0.000122	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—POMC—polycystic ovary syndrome	1.5e-05	0.000121	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.5e-05	0.00012	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.5e-05	0.00012	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—INS—polycystic ovary syndrome	1.5e-05	0.00012	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARG—polycystic ovary syndrome	1.48e-05	0.000119	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.46e-05	0.000117	CbGpPWpGaD
Danazol—AR—Gene Expression—NR3C1—polycystic ovary syndrome	1.46e-05	0.000117	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.45e-05	0.000116	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.45e-05	0.000116	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	1.43e-05	0.000115	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	1.42e-05	0.000114	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	1.41e-05	0.000113	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AR—polycystic ovary syndrome	1.39e-05	0.000111	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.37e-05	0.00011	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.37e-05	0.00011	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.37e-05	0.00011	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TH—polycystic ovary syndrome	1.35e-05	0.000108	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.34e-05	0.000108	CbGpPWpGaD
Danazol—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.33e-05	0.000107	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	1.33e-05	0.000106	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	1.32e-05	0.000106	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.32e-05	0.000105	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	1.31e-05	0.000105	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.27e-05	0.000102	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.27e-05	0.000102	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	1.25e-05	0.0001	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	1.21e-05	9.71e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.21e-05	9.7e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.19e-05	9.53e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.17e-05	9.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	1.16e-05	9.29e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	1.13e-05	9.04e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—polycystic ovary syndrome	1.13e-05	9.03e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	1.12e-05	8.98e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—polycystic ovary syndrome	1.11e-05	8.87e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	1.1e-05	8.85e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	1.1e-05	8.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.08e-05	8.67e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.08e-05	8.67e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.08e-05	8.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.08e-05	8.63e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	1.05e-05	8.43e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.03e-05	8.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.03e-05	8.24e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.02e-05	8.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1e-05	8.03e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	9.98e-06	7.99e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	9.85e-06	7.89e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	9.49e-06	7.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.49e-06	7.6e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.45e-06	7.57e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INS—polycystic ovary syndrome	9.43e-06	7.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	9.4e-06	7.53e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	9.3e-06	7.45e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	9.13e-06	7.31e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	9.12e-06	7.31e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.07e-06	7.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.92e-06	7.15e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	8.68e-06	6.96e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.67e-06	6.94e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.6e-06	6.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.27e-06	6.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.2e-06	6.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.88e-06	6.31e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	7.82e-06	6.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.73e-06	6.2e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	7.54e-06	6.04e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	7.44e-06	5.96e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—INS—polycystic ovary syndrome	7.4e-06	5.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.31e-06	5.86e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—polycystic ovary syndrome	7.15e-06	5.73e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.98e-06	5.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.62e-06	5.31e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—polycystic ovary syndrome	6.54e-06	5.24e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	6.48e-06	5.19e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.36e-06	5.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.22e-06	4.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.02e-06	4.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.96e-06	4.78e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.78e-06	4.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	5.57e-06	4.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.54e-06	4.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	5.54e-06	4.44e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.37e-06	4.3e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.36e-06	4.29e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.35e-06	4.29e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.17e-06	4.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.09e-06	4.08e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.97e-06	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.91e-06	3.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.64e-06	3.71e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.56e-06	3.66e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	4.12e-06	3.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.95e-06	3.16e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.84e-06	3.08e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.61e-06	2.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.5e-06	2.8e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.22e-06	2.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.07e-06	2.46e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.91e-06	2.33e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.71e-06	2.17e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	2.42e-06	1.94e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.2e-06	1.76e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.17e-06	1.74e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.16e-06	1.73e-05	CbGpPWpGaD
